Ivan de Kouchkovsky

2.0k total citations · 1 hit paper
31 papers, 1.2k citations indexed

About

Ivan de Kouchkovsky is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Ivan de Kouchkovsky has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 14 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Oncology. Recurrent topics in Ivan de Kouchkovsky's work include Prostate Cancer Treatment and Research (17 papers), Radiopharmaceutical Chemistry and Applications (12 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Ivan de Kouchkovsky is often cited by papers focused on Prostate Cancer Treatment and Research (17 papers), Radiopharmaceutical Chemistry and Applications (12 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Ivan de Kouchkovsky collaborates with scholars based in United States, Italy and France. Ivan de Kouchkovsky's co-authors include Maher Abdul‐Hay, Rahul Aggarwal, Els Fieremans, Matilde Inglese, Robert I. Grossman, Joseph Herbert, Lazar Fleysher, Thomas A. Hope, Lauren Krupp and Mark Gorman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Ivan de Kouchkovsky

25 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

‘Acute myeloid leukemia: a comprehensive review and 2016 update’

2016 928 citations Ivan de Kouchkovsky, Maher Abdul‐Hay Blood Cancer Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ivan de Kouchkovsky United States	8	582	561	228	205	163	31	1.2k
Roger Luo United States	16	694 1.2×	510 0.9×	130 0.6×	147 0.7×	220 1.3×	30	1.3k
Hiroshi Moritake Japan	17	301 0.5×	301 0.5×	181 0.8×	78 0.4×	99 0.6×	80	874
Lorena Lôbo de Figueiredo-Pontes Brazil	15	664 1.1×	228 0.4×	258 1.1×	300 1.5×	119 0.7×	50	1.1k
Lugui Qiu China	17	483 0.8×	397 0.7×	315 1.4×	146 0.7×	222 1.4×	125	1.0k
Antonella Gozzini Italy	22	752 1.3×	1.0k 1.9×	408 1.8×	117 0.6×	147 0.9×	75	1.7k
Francesco Paolo Tambaro United States	16	789 1.4×	294 0.5×	309 1.4×	160 0.8×	187 1.1×	40	1.3k
Liat Drucker Israel	20	537 0.9×	248 0.4×	320 1.4×	203 1.0×	109 0.7×	71	1.1k
Mack Mabry United States	19	1.2k 2.1×	611 1.1×	534 2.3×	139 0.7×	111 0.7×	31	1.8k
Francesca Arruga Italy	20	502 0.9×	394 0.7×	312 1.4×	149 0.7×	332 2.0×	60	1.3k
Jan Philipp Bewersdorf United States	26	707 1.2×	1.1k 2.0×	372 1.6×	97 0.5×	273 1.7×	137	1.8k

Countries citing papers authored by Ivan de Kouchkovsky

Since Specialization

Citations

This map shows the geographic impact of Ivan de Kouchkovsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan de Kouchkovsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan de Kouchkovsky more than expected).

Fields of papers citing papers by Ivan de Kouchkovsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan de Kouchkovsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan de Kouchkovsky. The network helps show where Ivan de Kouchkovsky may publish in the future.

Co-authorship network of co-authors of Ivan de Kouchkovsky

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan de Kouchkovsky. A scholar is included among the top collaborators of Ivan de Kouchkovsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan de Kouchkovsky. Ivan de Kouchkovsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Fei, Roxanna Juarez, Ivan de Kouchkovsky, et al.. (2025). Pre- or post-chemotherapy: effect on PSMA uptake. EJNMMI Research. 15(1). 36–36. 1 indexed citations

Kouchkovsky, Ivan de, Li Zhang, Xiaolin Zhu, et al.. (2025). Impact of baseline PSMA PET in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) starting first-line (1L) androgen receptor signaling inhibitor (ARSI) therapy.. Journal of Clinical Oncology. 43(5_suppl). 46–46.

Unterrainer, Lena M., Andrea Farolfi, Tristan Grogan, et al.. (2025). Early changes of PSMA PET expression after initiation of androgen receptor signaling inhibitors in CRPC: an international multicenter retrospective study. European Journal of Nuclear Medicine and Molecular Imaging. 52(10). 3700–3708.

Burger, Irene A., et al.. (2025). Evaluating survival in aggressive variant prostate cancer patients undergoing PSMA radioligand therapy.. Journal of Clinical Oncology. 43(5_suppl). 259–259.

Johns, Christopher, Hala T. Borno, Samuel L. Washington, et al.. (2025). Development of a culturally tailored educational tool designed to increase access to somatic testing among Black men with metastatic prostate cancer (mPCa).. Journal of Clinical Oncology. 43(16_suppl). 1591–1591.

Kouchkovsky, Ivan de, Hsin‐Yu Chen, Hecong Qin, et al.. (2024). Dual hyperpolarized [1-13C]pyruvate and [13C]urea magnetic resonance imaging of prostate cancer. SHILAP Revista de lepidopterología. 21. 100165–100165. 2 indexed citations

Yu, Evan Y., Luke T. Nordquist, Salim Yazji, et al.. (2024). A phase 1/2 study of ONCT-534, a dual-action androgen receptor inhibitor (DAARI), in patients with metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 42(16_suppl). TPS5111–TPS5111.

Jiang, Fei, Sarasa T. Kim, Roxanna Juarez, et al.. (2024). Real-World Experience with¹⁷⁷Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval. Journal of Nuclear Medicine. 65(5). 735–739. 8 indexed citations

Kwon, Daniel H., Hala T. Borno, Rohit Bose, et al.. (2024). Patients Can Administer Mobile Audio Recordings to Increase Knowledge in Advanced Prostate Cancer. Cancer Medicine. 13(22). e70433–e70433.

10.

Kouchkovsky, Ivan de, Emily Chan, Charles Schloss, Christian Poehlein, & Rahul Aggarwal. (2024). Diagnosis and management of neuroendocrine prostate cancer. The Prostate. 84(5). 426–440. 21 indexed citations

11.

Koshkin, Vadim S., Vipul Kumar, Matthew R. Cooperberg, et al.. (2024). Initial Experience with⁶⁸Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer. Journal of Nuclear Medicine. 65(2). 199–205. 14 indexed citations

12.

Zhu, Xiaolin, Li Zhang, Kevin Reyes, et al.. (2023). Association of biomarkers and response to immune checkpoint inhibitors (ICIs) in patients with metastatic urothelial carcinoma (mUC) with high and low tumor mutation burden (TMB).. Journal of Clinical Oncology. 41(6_suppl). 534–534. 2 indexed citations

13.

Reyes, Kevin, Li Zhang, Xiaolin Zhu, et al.. (2023). Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).. Journal of Clinical Oncology. 41(6_suppl). 532–532. 3 indexed citations

14.

Aggarwal, Rahul, Ivan de Kouchkovsky, Eric J. Small, et al.. (2022). 1379P A phase Ib study of a single priming dose of 177Lu-PSMA-617 coupled with pembrolizumab in metastatic castration resistant prostate cancer (mCRPC). Annals of Oncology. 33. S1173–S1173. 2 indexed citations

15.

Kwon, Daniel H., Julian C. Hong, Osama Mohamad, et al.. (2022). Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers. Urologic Oncology Seminars and Original Investigations. 41(3). 145.e7–145.e15. 2 indexed citations

16.

Kouchkovsky, Ivan de, Dohee Kwon, Hala T. Borno, et al.. (2022). 1404P A phase II study of ZEN-3694 (ZEN), enzalutamide (ENZ), and pembrolizumab (P) in metastatic castration resistant prostate cancer (mCRPC): Interim safety results. Annals of Oncology. 33. S1187–S1187. 3 indexed citations

17.

Kouchkovsky, Ivan de, Rahul Aggarwal, & Thomas A. Hope. (2021). Prostate-specific membrane antigen (PSMA)-based imaging in localized and advanced prostate cancer: a narrative review. Translational Andrology and Urology. 10(7). 3130–3143. 13 indexed citations

18.

Baumgartner, Christine, Ivan de Kouchkovsky, Evans Whitaker, & Margaret C. Fang. (2019). Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review. The American Journal of Medicine. 132(6). 722–732.e7. 7 indexed citations

19.

Kouchkovsky, Ivan de & Maher Abdul‐Hay. (2016). ‘Acute myeloid leukemia: a comprehensive review and 2016 update’. Blood Cancer Journal. 6(7). e441–e441. 928 indexed citations breakdown →

20.

Kouchkovsky, Ivan de, Els Fieremans, Lazar Fleysher, et al.. (2016). Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study. Journal of Neurology. 263(6). 1146–1155. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact